213 related articles for article (PubMed ID: 28767505)
21. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
22. The endocannabinoid system and pain.
Guindon J; Hohmann AG
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937
[TBL] [Abstract][Full Text] [Related]
23. Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats.
Petrosino S; Palazzo E; de Novellis V; Bisogno T; Rossi F; Maione S; Di Marzo V
Neuropharmacology; 2007 Feb; 52(2):415-22. PubMed ID: 17011598
[TBL] [Abstract][Full Text] [Related]
24. No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.
Hu SS; Ho YC; Chiou LC
Eur J Neurosci; 2014 Feb; 39(3):467-84. PubMed ID: 24494686
[TBL] [Abstract][Full Text] [Related]
25. Alterations in Anandamide Synthesis and Degradation during Osteoarthritis Progression in an Animal Model.
Bryk M; Chwastek J; Kostrzewa M; Mlost J; Pędracka A; Starowicz K
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036283
[TBL] [Abstract][Full Text] [Related]
26. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.
Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V
J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510
[TBL] [Abstract][Full Text] [Related]
27. Pain Inhibits Pain: an Ascending-Descending Pain Modulation Pathway Linking Mesolimbic and Classical Descending Mechanisms.
Tobaldini G; Sardi NF; Guilhen VA; Fischer L
Mol Neurobiol; 2019 Feb; 56(2):1000-1013. PubMed ID: 29858776
[TBL] [Abstract][Full Text] [Related]
28. Changes in cannabinoid receptor subtype 1 activity and interaction with metabotropic glutamate subtype 5 receptors in the periaqueductal gray-rostral ventromedial medulla pathway in a rodent neuropathic pain model.
Palazzo E; Luongo L; Bellini G; Guida F; Marabese I; Boccella S; Rossi F; Maione S; de Novellis V
CNS Neurol Disord Drug Targets; 2012 Mar; 11(2):148-61. PubMed ID: 22483283
[TBL] [Abstract][Full Text] [Related]
29. Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats.
Rivera P; Luque-Rojas MJ; Pastor A; Blanco E; Pavón FJ; Serrano A; Crespillo A; Vida M; Grondona JM; Cifuentes M; Bermúdez-Silva FJ; de la Torre R; de Fonseca FR; Suárez J
Eur J Neurosci; 2013 Jan; 37(1):105-17. PubMed ID: 23033907
[TBL] [Abstract][Full Text] [Related]
30. Postnatal maturation of the spinal-bulbo-spinal loop: brainstem control of spinal nociception is independent of sensory input in neonatal rats.
Schwaller F; Kwok C; Fitzgerald M
Pain; 2016 Mar; 157(3):677-686. PubMed ID: 26574823
[TBL] [Abstract][Full Text] [Related]
31. A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis.
Hasanein P; Javanmardi K
Fundam Clin Pharmacol; 2008 Oct; 22(5):517-22. PubMed ID: 18844724
[TBL] [Abstract][Full Text] [Related]
32. Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Silva M; Martins D; Charrua A; Piscitelli F; Tavares I; Morgado C; Di Marzo V
Neuropharmacology; 2016 Aug; 107():49-57. PubMed ID: 26965218
[TBL] [Abstract][Full Text] [Related]
33. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
34. Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.
Sagar DR; Staniaszek LE; Okine BN; Woodhams S; Norris LM; Pearson RG; Garle MJ; Alexander SP; Bennett AJ; Barrett DA; Kendall DA; Scammell BE; Chapman V
Arthritis Rheum; 2010 Dec; 62(12):3666-76. PubMed ID: 20722027
[TBL] [Abstract][Full Text] [Related]
35. Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception.
Godoi MM; Junior HZ; da Cunha JM; Zanoveli JM
Pharmacol Biochem Behav; 2020 Jul; 194():172938. PubMed ID: 32376258
[TBL] [Abstract][Full Text] [Related]
36. Analgesic effects of cannabinoid receptor agonist WIN55,212-2 in the nucleus cuneiformis in animal models of acute and inflammatory pain in rats.
Ebrahimzadeh M; Haghparast A
Brain Res; 2011 Oct; 1420():19-28. PubMed ID: 21911208
[TBL] [Abstract][Full Text] [Related]
37. Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli.
Rea K; Olango WM; Okine BN; Madasu MK; McGuire IC; Coyle K; Harhen B; Roche M; Finn DP
Pain; 2014 Jan; 155(1):69-79. PubMed ID: 24076311
[TBL] [Abstract][Full Text] [Related]
38. Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat.
Morgan MM; Clayton CC; Boyer-Quick JS
Pain; 2005 Jan; 113(1-2):91-8. PubMed ID: 15621368
[TBL] [Abstract][Full Text] [Related]
39. The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg E; Larsson N; Sjögren S; Hjorth S; Hermansson NO; Leonova J; Elebring T; Nilsson K; Drmota T; Greasley PJ
Br J Pharmacol; 2007 Dec; 152(7):1092-101. PubMed ID: 17876302
[TBL] [Abstract][Full Text] [Related]
40. Alterations in the rostral ventromedial medulla after the selective ablation of μ-opioid receptor expressing neurons.
Harasawa I; Johansen JP; Fields HL; Porreca F; Meng ID
Pain; 2016 Jan; 157(1):166-173. PubMed ID: 26335909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
